A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient

Yilmaz R., Akoglu H. , Yirkpantur A., Kilickap S. , Arici M. , Altun B. , ...Daha Fazla

RENAL FAILURE, cilt.29, sa.1, ss.103-105, 2007 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 29 Konu: 1
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1080/08860220601039528
  • Dergi Adı: RENAL FAILURE
  • Sayfa Sayıları: ss.103-105


Renal transplant recipients are susceptible to Kaposi's sarcoma (KS) because of treatment with immunosuppressive drugs. Sirolimus, a new immunosuppressive agent, has been successfully used for immune-suppression in kidney transplant recipients. Several studies have shown the potential role of sirolimus to inhibit progression of KS in kidney-transplant recipients. This report details a kidney-transplant recipient with cutaneous KS who had a complete remission in response to sirolimus therapy.